logo
Plus   Neg
Share
Email

Poseida Therapeutics Prices Upsized IPO Of 14 Mln Shares At $16/Shr

Poseida Therapeutics, Inc. announced the pricing of initial public offering of 14 million shares of common stock at $16.00 per share. The company expects to close the offering on July 14, 2020.

The company has originally filed to sell 10.0 million shares at a range of $14 to $16 share. Earlier on July 9, the company raised the proposed offer shares to 14 million shares at an expected IPO price of $16 per share.

Poseida Therapeutics shares are expected to begin trading on Nasdaq Global Select Market on July 10, under the symbol "PSTX". The company expects offering gross proceeds, before expenses, to be $224.0 million.

In addition, Poseida has granted the underwriters a 30-day option to buy additional 2.1 million common shares at the initial public offering price less underwriting discounts and commissions.

BofA Securities, Piper Sandler and William Blair are acting as joint book-running managers for the offering.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The media mogul and Billionaire Sumner Redstone passed away on Tuesday at the age of 97, his family's holding company National Amusements said in a statement on Wednesday. He was Chairman Emeritus of ViacomCBS and chief executive officer of National Amusements. Customers in the U.S. are preferring digital or touchless payment methods due to concerns arising from the COVID-19 pandemic, a survey said. According to the survey by Rapyd Financial Network, the coronavirus pandemic has raised health and safety concerns around using cash and coins, and is accelerating the pre-existing trend toward digital transactions. American Airlines has extended its offer to waive change fees for customers who purchase tickets for travel, until December 31, 2020 in response to lower travel demand due to the coronavirus pandemic. This means that the travelers need not pay penalties for changing the origin and destination cities.
Follow RTT